课题基金 / 基金详情

Copper-ionophores as a treatment for prostate cancer?

Copper-ionophores as a treatment for prostate cancer?
铜离子载体可以治疗前列腺癌吗?
批准号:
nhmrc : 1027125
负责人:
Dr Michael Cater
金额:
$20.95万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2012
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2012-01-01 至 2017-12-31

项目摘要

项目成果

Dr Michael Cater的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overarching aim of this project is to evaluate a potential therapy for prostate cancer, which targets a distinct characteristic of the disease 'elevated copper'. Our copper-based drugs in the laboratory selectively destroy cancerous prostate cells without harming normal cells. We will verify whether these drugs work in the body where the environment is more complex. Proof of this principle will open up a new area of research and provide a novel therapeutic approach for prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuronal copper homeostasis and the role of the Alzheimer Amyloid-Beta Precursor Protein (APP)
  • 批准号:
    nhmrc : 520345
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $19.16万
  • 财政年份:
    2008
  • 负责人:
    Dr Michael Cater
  • 依托单位:
海外基金